Podiatrists in Willoughby Hills, OH Accepting Medicare
9 Podiatrists found. Showing 1 - 9
 Lake Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 35010 Chardon Rd, 101a, Willoughby Hills, OH 44094 Phone: 440-953-1003 Fax: 440-953-3556 |
 Dr. Timothy Jason Levar, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 34600 Chardon Rd, Suite 9, Willoughby Hills, OH 44094 Phone: 440-585-5258 Fax: 440-944-5278 |
Dr. Vadim Glukh, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 35010 Chardon Rd, Suite 101a, Willoughby Hills, OH 44094 Phone: 440-953-3668 Fax: 440-953-3556 |
Dr. Mark A. Tozzi Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 34600 Chardon Road, Suite 9, Willoughby Hills, OH 44094 Phone: 440-944-5255 Fax: 440-944-5278 |
Dr. Brian Andrew Koludrovich, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 35010 Chardon Rd Ste 101a, Willoughby Hills, OH 44094 Phone: 440-953-3668 Fax: 440-953-3556 |
North Eastern Ohio Podiatry Group Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 35010 Chardon Rd, Suite 101a, Willoughby Hills, OH 44094 Phone: 440-953-3668 Fax: 440-953-3556 |
Howard Waxman Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 35000 Chardon Rd Ste 220, Willoughby Hills, OH 44094 Phone: 440-571-5515 Fax: 440-571-5537 |
Dr. Atta J Asef, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 35010 Chardon Road, Suite #101a, Willoughby Hills, OH 44094 Phone: 440-953-3668 Fax: 440-953-3556 |
Dr. Howard Waxman, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 35000 Chardon Rd, Ste 220, Willoughby Hills, OH 44094 Phone: 440-571-5515 Fax: 440-571-5537 |
News Archive
NEOP receives stockholder approval to increase company shares to 205 milliion
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced at its 2010 Annual Meeting of Stockholders that it received the approval of its stockholders to increase the number of authorized shares of the Company from 155 million to 205 million. In addition, stockholders re-elected Neoprobe President and CEO David C. Bupp, and elected for the first time, Brendan A. Ford and Eric K. Rowinsky, M.D. as Directors of the Company for terms ending at the 2013 Annual Meeting. Stockholders also approved the appointment of BDO Seidman, LLP to act as the Company's independent registered public accounting firm for 2010.
Invida, Roche partner to commercialize primary care products
Invida Group Pte Ltd, the leading specialty pharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into a partnership agreement with Roche for the commercialization and marketing of that company's primary care portfolio throughout Korea.
Study confirms Stretta therapy as safe, effective treatment for GERD
A newly published peer-reviewed paper concludes that Stretta therapy is a safe, effective and durable treatment for gastro esophageal reflux disease (GERD). The paper states that Stretta addresses a significant unmet need where patients receive inadequate control from PPI therapy and find surgery an undesirable option.
Acquisition of Standard Life Healthcare strengthens PruHealth PMI market scale
PruHealth has become a competitor of scale in the UK Private Medical Insurance (PMI) market following the completion of the acquisition of Standard Life Healthcare by Discovery Holdings of South Africa.
› Verified 6 days ago
Physical Therapists
Podiatrists
Chiropractors
Optometrists
Occupational Therapists
Audiologists
Speech-Language Pathologists